NASDAQ · Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc (AQST)
$4.78
+0.42%
52
In band
Moving averages
SMA 200$4.45+7.42%
Company profile
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$603.71M
P/E ratioNone
EPS$-0.65
Beta1.471
Dividend yield0.00%
52-week high$7.55
52-week low$2.93
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 57
CGC
Canopy Growth Corporation
RSI 28
BFRI
Biofrontera Inc
RSI 36
TLRY
Tilray Brands Inc - Class 2
RSI 33
LNTH
Lantheus Holdings Inc
RSI 48
ACB
Aurora Cannabis Inc
RSI 67
BCRX
Biocryst Pharmaceuticals Inc
RSI 49
INM
InMed Pharmaceuticals Inc
RSI 50
ORGO
Organogenesis Holdings Inc - Class A
RSI 33
ZTS
Zoetis Inc - Class A
RSI 57
RSI alerts for AQST
Get an email the moment Aquestive Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 17 September 2026 at 3:59 AM EDT